DOCSLIB.ORG

Substance Abuse by Adolescents in 1977 with 499 French Adolescents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Substance Abuse by Adolescents in 1977 with 499 French Adolescents In a country like Israel, which is deeply committed to the main sources of infection, among them active foci achievement of an expanded immunization program, the still present in the neighboring territories. effort to reach this objective should be weighed within the national program aimed at elimination of the diseases References .................................. controlled by mass immunization. Analysis of present achievements clearly shows that measles, together with 1. Swartz, T. A., and Klingberg, W.: Routine measles immu- poliomyelitis and rubella, deserves to be included among nization in Israel: A three-year clinical and serologic follow- up. In International conference on application of vaccines the first priorities of a program whose objective is elim- against viral, rickettsial, and bacterial diseases of man, ination of clinical disease. Washington, D.C., 14-18 December 1970. Pan American Health Organization, Washington, D.C., 1971, pp. Conclusions 265-268. 2. Centers for Disease Control: Measles Surveillance Report No. 11, 1977-1981. Atlanta, Ga., September 1982. A 17-year-old immunization program has created the 3. Health and Welfare Canada: Measles in Canada. Canada basis for elimination of measles in Israel, provided that Diseases Weekly Report 9-25: 29-101 (1983). (a) the control policy is adapted to the seroepidemiology 4. World Health Organization: Measles surveillance. Weekly of the infection, and (b) a concentrated logistic effort is Epidemiol Record 58: 85-86 (1983). mounted in the period preceding the next expected epi- 5. Hopkins, D. R., Hinman, A. R., Kaplan, J. E, and Lane, J. M.: The case for global measles eradication. Lancet 1: demic. Under this effort: 1936-1938, June 19, 1982. 6. Public Health Laboratory Service: Goal to eliminate mea- * The nearly 90 percent vaccination coverage of each sles from the United States. Communicable Diseases Re- newborn cohort that has already been achieved should be port, No. 1: 1,4 (1979). maintained. 7. Yorke, J. A., Nathanson, N., Pianigiani, G., and Martin, J.: Seasonality and the requirements for perpetuation and erad- * A 97 percent immunization coverage should be aimed ication of viruses in populations. Am J Epidemiol 109: at for the target groups formed by preschool and elemen- 103-123, February 1979. tary school children who missed the routine immuniza- 8. Hethcote, H. W.: Measles and rubella in the United States. tion at age 1 year. Am J Epidemiol 117: 2-13, January 1983. * Similar coverage should be achieved by immunization 9. Centers for Disease Control: Classification of measles cases and categorization of measles elimination programs. of susceptible persons in selected groups of children, MMWR 31: 707-711 (1982). adolescents, and young adults at high risk. 10. World Health Organization: Measles surveillance in U.S.A. * The immunization program should be complemented Weekly Epidemiol Record 57: 367-368 (1982). by disease surveillance aimed at early identification of Substance Abuse by Adolescents in 1977 with 499 French adolescents. The overall order in the prevalence of use of legal and illegal drugs was In Israel and France: identical in both countries. Cigarettes and alcohol were A Cross-Cultural Perspective used by a larger proportion of young people than the illegal drugs; marijuana was used much morefrequently DENISE KANDEL, PhD than any other illicit drug. The same cumulative se- Dr. Kandel is professor of public health, Department of Psychia- quence of drug use appeared in the survey data for try, Columbia University, Box 20, 722 West 168th St., New York, French and Israeli adolescents as in comparative data N.Y. 10032. This paper is based on her presentation at the Second for adolescents in the United States-cigarette and alco- Binational Symposium: United States-Israel, held October 17-19, hol use preceded the use of illicit drugs. 1983, in Bethesda, Md. This research was partially supported by grant DA 01097 Scope E and by Research Scientist Award DA00081 from the National Striking cross-cultural differences appeared in the Institute on Drug Abuse. overall lifetime and current prevalences of use of all Tearsheet requests to Dr. Kandel. drugs, in the frequency of use, and in the age- and sex- specific rates for adolescents in Israel and in France. Synopsis .................................... French youths uniformly reported greater lifetime and current use of all alcoholic beverages, cigarettes, and Household surveys ofurban youths 14-18 years ofage illegal drugs, more extensive involvement, and smaller were conducted in 1979 with 609 Israeli adolescents and sex differences than the Israeli youths. May-June 1984, Vol. 99, No. 3 277 Prevalence of the use ofdrugs in a culture appears to sults suggest a relatively conservative position with re- be associated with four social processes: higher number gard to accessibility and availability of substances: re- of times each drug has been used; greater persistence of ducing availability may be one way to reduce individual involvement, as reflected by the proportions of current consumption by impinging not on individual persons users among those who ever tried a particular drug; directly but on society. earlier age offirst use; and a spread of the phenomenon throughout all groups in society that attenuates group differences in drug experiences. These cross-cultural re- CROSS-CULTURAL EPIDEMIOLOGIC DATA permit in- Methods sights into drug use behavior that cannot be gained with data for a single country. This is especially true when Two household surveys of urban youths 14-18 years there are great contrasts in drug use in the cultures being old were conducted (a) in the spring of 1979, with 609 compared. Data for a wide range of substances raise Israeli adolescents who resided in the four major urban provocative questions with important policy implica- centers in Israel-Jerusalem, Tel Aviv, Haifa, and tions: Beersheba, and (b) in the spring of 1977, with 499 French youths in the Paris metropolitan area. All inter- * What is the relationship between the overall consump- views were structured, and they were conducted in tion levels and the patterns of use of a substance in a homes. particular culture? Because the Israeli sample included a lower proportion * What are the implications of the use of one substance of 18-year-olds than the French sample (13 percent ver- for the use of other substances? How do stages of in- sus 26 percent), data were weighted to create a uniform volvement affect use of other drugs? distribution for each category in the age variable for each country. Cross-cultural studies in Israel and France were con- I focused on three dimensions of drug use: lifetime ducted to test specific hypotheses derived from earlier prevalence-that is, the proportion who had ever used work with American adolescents and to replicate in other each drug; current use, defined as use in the 30 days societies the epidemiologic and psychosocial studies of before the interview; and lifetime frequency of use for adolescents in the United States. Earlier analyses in the each drug. With certain exceptions, the same questions United States indicated that the uses of legal and illegal were asked for all drugs in both surveys. Adjustments drugs were closely interrelated and that illicit drug use were made in the alcoholic beverages listed in the ques- was preceded by the use of legal drugs, with alcohol use tions to reflect the range of beverages consumed in each a crucial step in this sequence (1,2a,3). An important country. In Israel, "white beer" was specified to avoid issue, therefore, is whether wide differences in the use of confusion with a nonalcoholic beverage known as "black alcoholic beverages between cultures affect the use of beer." I also distinguished ritualistic and nonritualistic other drugs in those cultures. uses of wine. My reporting will be confined to non- France and Israel were selected for comparative analy- ritualistic use. In France, questions were included about sis because of the striking differences in their patterns of cider, and "aperitifs" and "digestifs" were specified alcohol consumption, as documented by indirect con- among distilled spirits. sumption indicators such as alcohol sales volume and For comparative purposes, data will be drawn from the alcohol-related disabilities. According to these indica- 1979 national survey of high school seniors from tors, Israel had one of the lowest rates of alcoholism and Monitoring the Future, an ongoing study conducted by per capita consumption of alcohol and France had one of the University of Michigan on an annual basis since 1975 the highest rates in the world. On per capita consump- (8-9). The sample of high school seniors included over tion, France ranked 2nd out of 26 countries, Israel 15,000 17- and 18-year-olds from 130 high schools in ranked 26th and last, and the United States ranked 16th urban and nonurban areas. The questions in the Ameri- (4). can survey were phrased somewhat differently from those In contrast to the United States, there were almost no in the French and Israeli surveys. epidemiologic data in Israel and France on drug use- "Drug" is used through this paper to mean tobacco, whether tobacco, alcohol, or illicit drugs-by adoles- alcoholic beverages, and legal and illegal drugs. The cents or adults (5-7). term "legal drugs" indicates alcoholic beverages and 278 Public Health Reports tobacco. Illegal drugs include marijuana and/or hashish, psychedelics, heroin, and use on one's own of psycho- tropic drugs that can be medically prescribed, such as amphetamines, barbiturates, and tranquilizers. Results Epidemiologic trends. Striking cross-cultural dif- ferences for all drugs appeared in the proportions of those who had ever used them (lifetime prevalence), or were current users, in the frequency of use and in the age of onset of use. Lifetime and current use prevalences. For all drugs having used hashish or marijuana, a proportion similar to surveyed, the rates of reported use in France exceeded the 5 and 4 percent reported in 1971 and 1973 Israeli those in Israel.
Load more

Recommended publications
  • Drug Use Sequencing and Kandel's Gateway Hypothesis John Reid Clemson University, [email protected]
    Clemson University TigerPrints All Theses Theses 8-2008 Drug Use Sequencing and Kandel's Gateway Hypothesis John Reid Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_theses Part of the Sociology Commons Recommended Citation Reid, John, "Drug Use Sequencing and Kandel's Gateway Hypothesis" (2008). All Theses. 447. https://tigerprints.clemson.edu/all_theses/447 This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized administrator of TigerPrints. For more information, please contact [email protected]. DRUG USE SEQUENCING AND KANDEL'S GATEWAY HYPOTHESIS A Thesis Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Master of Science Applied Sociology by John Matthew Reid August 2008 Accepted by: Dr. Brenda Vander Mey, Committee Chair Dr. Douglas Kinly Sturkie Dr. Margaret Tina Britz i ABSTRACT This thesis tests the hypothesis by Kandel (1975) that there is a specific sequence of drug use that users follow. Using the same scalogram analysis technique utilized by Kandel in her original Gateway Hypothesis study, a distinct sequence of use was discovered. This thesis is based on the National Survey on Drug Use and Health (2005). This study confirmed Kandel’s earlier findings in that this study determined that there is a sequence of drug use. The current study also confirms Kandel’s position that licit drugs precede the use of illicit drugs. This study’s findings differ from those of Kandel, however, in that tobacco and not alcohol was found to be the first drug of experimentation.
    [Show full text]
  • A Molecular Basis for Nicotine As a Gateway Drug
    The new england journal of medicine special article shattuck lecture A Molecular Basis for Nicotine as a Gateway Drug Eric R. Kandel, M.D., and Denise B. Kandel, Ph.D. From the Howard Hughes Medical Insti- n the historic occasion of the 122nd Shattuck Lecture and tute (E.R.K.), Kavli Institute for Brain Sci- the 200th anniversary of the New England Journal of Medicine, we chose to ad- ence (E.R.K.), and the Departments of Neuroscience (E.R.K.) and Psychiatry Odress a topic that is at once scientific and personally historic. In recent (E.R.K., D.B.K.), College of Physicians debates over legalizing marijuana, from all-out acceptance in Colorado to narrow and Surgeons, and Mailman School of decriminalization in Maryland, the scientific question of the role of marijuana as a Public Health (D.B.K.), Columbia Univer- sity, and the New York State Psychiatric gateway drug (i.e., a drug that lowers the threshold for addiction to other agents) Institute (D.B.K.) — all in New York. Ad- has loomed large. Both opponents and proponents of legalization have distorted dress reprint requests to Dr. E. Kandel at what science does and does not tell us — and both sides have overlooked the im- the Department of Neuroscience, Col- lege of Physicians and Surgeons, Colum- portance of nicotine as a gateway drug. bia University, 1051 Riverside Dr., Unit Epidemiologic studies have shown that nicotine use is a gateway to the use of 87, New York, NY 10032, or at erk5@ marijuana and cocaine in human populations.
    [Show full text]
  • 2016 and Over 4,000 Research Scientists, 168 Scientific Leaders and 60,000 Was Our Leader and Guiding Light, Providing Inspiration and Moti- Pression
    INVEST IN MENTAL HEALTH ANNUAL REPORT 2 0 1 6 Dear Brain & Behavior Research Foundation Supporters: From mental illness to mental health–30 years of achievements by tremendous impact on psychiatric research and treatment. Connie problems improves symptoms of some patients with refractory de- The Foundation is proud of our accomplishments in 2016 and over 4,000 research scientists, 168 scientific leaders and 60,000 was our leader and guiding light, providing inspiration and moti- pression. In a study of patients with treatment-resistant depression, we are excited to focus on the promising path of discovery. With donors. We are proud to present you with our 2016 annual report vation to all who ever had the honor and privilege of knowing and about two thirds had metabolic deficiencies that affect the brain’s your sustained commitment, we will accelerate the funding of our and invite you to invest in mental health. working with her. She will be dearly missed by us all. But her legacy ability to produce neurotransmitters. Dr. Pan’s research found Grants and continue to lead the field with breakthroughs that continues with each new scientist which we support and each new that patients’ depression symptoms declined significantly when improve the lives of those living with mental illness. Thank you for Since 1987, the Brain & Behavior Research Foundation has invest- discovery which improves people’s lives. their metabolic problems were treated. Some of the patients even continuing the journey with us. ed in the future. We support the innovative brain and behavior reached remission. The most common of the deficiencies observed research today which will lead to new treatments and eventual While we are proud of our accomplishments, there is still much in the participants was in levels of cerebral folate, which is treat- Sincerely, cures in the future.
    [Show full text]
  • DOCUMENT RESUME ED 222 832 CG 016 300 AUTHOR Lettieri, Dan
    DOCUMENT RESUME ED 222 832 CG 016 300 AUTHOR Lettieri, Dan J., Ed.; Ludford, Jacqueline P., Ed. TITLE Drug Abuse and the American Adolescent. NIDA Research Monograph 38. A RAUS Review Report. INSTITUTION National Inst. on Drug Abuse (DHHS), Rockville, Md. Div. of Research. REPORT NO DHHS-ADM-81-1166 PUB DATE 8 Sep 80 NOTE 140p.; Papers presented at the Research Analysis and Utilization System (RAUS) Review Conference on Drug Abuse and the American Adolescent (Rockville, MD, September 8, 1980). AVAILABLE FROMSuperintendent of Documents, U.S. Government Printing Office, Washington, DC 20402. PUB TYPE Collected Works - Conference Proceedings (021) Reference Materials - Bibliographies (131) Reports Research/Technical (143) EDRS PRICE MF01/PC06 Plus Postage. DESCRIPTCRS *Adolescents; Biomedicine; Cohort Analysis; *Delinquent Behavior; Drinking; *Drug Abuse; Individual Differences; Literature Reviews; Longitudinal Studies; *Peer Influence; Personality Traits; *Predictor Variables; Secondary Education; *Youth Problems IDENTIFIERS *Epidemiology ABSTRACT This report reviews five studiei-dealing with drug abuse and adolescence and presents an overview of the social changes which have contributed to the increased use of marijuana and other illicit drugs. The importance of the longitudinal study as a research tool is emphasized in describing the research projects that dealwith the epidemiology of drug use, personality and sociodemographic factors, peer influence, the relationship between delinquency and drug use, and its biomedical consequences. The report closes with an executive summary, discussion, and suggestions for further research. An annotated list of NIDA (National Institute of DrugAbuse) research monographs is included. (JAC) *********************************************************************** Reproductions supplied by EDRS are the best that can be made from the original document. *********************************************************************** Drug Abuse and the American Adolescent Editors: Dan J.
    [Show full text]
  • Is Cannabis a Gateway Drug? Key Findings and Literature Review
    U.S. Department of Justice Office of Justice Programs National Institute of Justice National Institute of Justice Is Cannabis a Gateway Drug? Key Findings and Literature Review Wm. Nel, MSc, Researcher Judy Wang, PhD, Researcher November 2018 A Report Prepared by the Federal Research Division, Library of Congress, Under an Interagency Agreement with the Office of the Director, National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. NCJ 252950 U.S. Department of Justice Office of Justice Programs 810 Seventh St. N.W. Washington, DC 20531 David B. Muhlhausen, Ph.D. Director, National Institute of Justice This and other publications and products of the National Institute of Justice can be found at: National Institute of Justice Strengthen Science • Advance Justice nij.ojp.gov Office of Justice Programs Building Solutions • Supporting Communities • Advancing Justice O J P.gov The National Institute of Justice is the research, development, and evaluation agency of the U.S. Department of Justice. NIJ’s mission is to advance scientific research, development, and evaluation to enhance the administration of justice and public safety. The National Institute of Justice is a component of the Office of Justice Programs, which also includes the Bureau of Justice Assistance; the Bureau of Justice Statistics; the Office for Victims of Crime; the Office of Juvenile Justice and Delinquency Prevention; and the Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking. Opinions or conclusions expressed in this paper are those of the authors and do not necessarily reflect the official position or policies of the U.S. Department of Justice.
    [Show full text]
  • 17Th European Society for Biomedical Research on Alcoholism Congress 21-24 September 2019, Lille – Invited Talks and Symposia Abstracts
    Directeur de la rédaction Pr François Paille Rédacteur en chef Pr Amine Benyamina Rédacteurs associés Dr Philippe Batel Dr Ivan Berlin Dr Laurent Karila Pr Michel Lejoyeux Pr Mickaël Naassila Rédactrice Sciences humaines Pr Myriam Tsikounas Rédactrice Sciences psychologiques Pr Isabelle Varescon-Pousson Comité de rédaction Pr Georges Brousse Pr Olivier Cottencin Dr Michel Craplet Pr Jean-Bernard Daeppen Dr Jean-Michel Delile Pr Maurice Dematteis Dr Claudine Gillet th Dr Geneviève Lafaye 17 European Society for Biomedical Research Pr Michel Reynaud Dr Alain Rigaud Dr Marc Valleur on Alcoholism Congress Directeur de la publication Pr Mickael Naassila 21-24 September 2019, Lille Comité scientifique Pr Jean Adès Pr Thomas F. Babor Pr Jean-Louis Balmès Pr Maurice Bazot Dr Mats Berglund Pr Jacques Besson Pr Jean-Pierre Blayac Pr Jonathan D. Chick Mme Marie Choquet Pr Philippe de Witte Pr Michel Escande Pr Claude Got Dr Antoni Gual Pr Momar Gueye Pr Roger Henrion Pr Denise Kandel Pr Michel Le Moal Pr Karl Mann Mme Véronique Nahoum-Grappe Dr José Maria Neves Cardoso Pr Philippe-Jean Parquet Pr Jean-Louis Pedinielli Pr Falvio Poldrugo Pr Bernard Roques Pr John A. Talbott Pr Jean-Luc Vénisse Pr Lars von Knorring Pr Jacques Weill Pr Jean-Jacques Yvorel ISSN 2554-4853 Trimestriel Société Française PRINCEPS Éditions SEPTEMBRE-DÉCEMBRE 2019 - Tome 41, n° 3-4 d’Alcoologie !BSTRACTS CONGRÈS Pr Mickael Naassila* * President 17th ESBRA Meeting 17th European Society for Biomedical Research on Alcoholism congress 21-24 September 2019, Lille – Invited talks and Symposia abstracts Invited talks forward, such as combining training with neurostimulation.
    [Show full text]
  • Cocaine Use in America: Epidemiologic and Clinical Perspectives
    DOCUMENT RESUME ED 268 463 CG 019 022 AUTHOR Kozel, Nicholas J., Ed.; Adams, Edgar H., Ed. TITLE Cocaine Use in America: Epidemiologic and Clinical Perspectives. National Institute on Drug Abuse (NIDA) Research Monograph Series 61. INSTITUTION National Inst. on Drug Abuse (DHHS/PHS), Rockville, Md. REPORT NO DHHS-ADM-85-1414 PUB DATE 85 NOTE 243p. AVAILABLE FROMSuperintendent of Documents, U.S. Government Printing Office, Washington, DC 20402. PUB TYPE Reports - Research/Technical (143) -- Collected Works General (020) EDRS PRICE MF01/PC10 Plus Postage. DESCRIPTORS *Adolescents; *Behavior Patterns; *Drug Abuse; *Illegal Drug Use; Individual Characteristics; *Trend Analysis; *Young Adults IDENTIFIERS *Cocaine ABSTRACT This monograph is based on papers presented at a technical review of patterns of cocaine use in the United States which was held in 1984. The foreword by Jerome H. Jaffe acknowledges that, over the past 10 years, cocaine has become a major public health threat in this country. Papers contained in this monograph include: (1) "Cocaine Use in America: Introduction and Overview" by Edgar H. Adams and Nicholas J. Kozel; (2) "Cocaine Use in the United States: In a Blizzard or Just Being Snowed?" by Richard R. Clayton; (3) "A Decade of Trends in Cocaine Use in the Household Population" by Herbert I. Abelson and Judith Droitcour Miller; (4) "Cocaine Use Among American Adolescents and Young Adults" by Patrick M. O'Malley, Lloyd D. Johnston, and Jerald G. Bachman; (5) "Cocaine Use in Young Adulthood: Patterns of Use and Psychosocial Correlates" by Denise B. Kandel, Debra Murphy, and Daniel Karus; (6) "Patterns and Consequences of Cocaine Use" by Dale D.
    [Show full text]
  • Preventing Adolescent Drug Abuse: Intervention Strategies, 47
    RESEARCH ANALYSIS and UTILIZATION SYSTEM Preventing Adolescent Drug Abuse: Intervention Strategies U. S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Preventing Adolescent Drug Abuse Intervention Strategies Editors: Thomas J. Glynn, Ph.D. Carl G. Leukefeld, D.S.W. Jacqueline P. Ludford, M.S. National Institute on Drug Abuse NIDA Research Monograph 47 A RAUS Review Report DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 NIDA Research Monographs are prepared by the research divtsrons of the National lnstitute on Drug Abuse and published by its Office of Science. The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph D. SIDNEY COHEN, M.D Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth Omaha, Nebraska RICHARD E. BELLEVILLE, Ph.D. NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric Institute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C DENISE KANDEL, Ph.D.
    [Show full text]
  • NCI Cancer Prevention Fellowship Program
    DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE NATIONAL INSTITUTES OF HEALTH NATIONAL CANCER INSTITUTE 4TH JOINT MEETING OF THE BOARD OF SCIENTIFIC ADVISORS AND THE NATIONAL CANCER ADVISORY BOARD Summary of Meeting December 2, 2014 Building 31C, Conference Room 10 National Institutes of Health Bethesda, Maryland 4th Joint Meeting of the Board of Scientific Advisors and the National Cancer Advisory Board NATIONAL CANCER ADVISORY BOARD BETHESDA, MARYLAND Summary of Meeting December 2, 2014 The Board of Scientific Advisors (BSA) and the National Cancer Advisory Board (NCAB) convened for the 4th Joint Meeting on 2 December 2014, in Conference Room 10, C Wing, Building 31, National Institutes of Health (NIH), Bethesda, MD. The meeting was open to the public on Tuesday, 2 December 2014, from 8:30 a.m. to 12:30 p.m. and 1:15 p.m. to 4:55 p.m., and closed to the public from 12:30 p.m. to 1:15 p.m. The BSA Chair, Todd R. Golub, Chief Scientific Officer, The Broad Institute of Harvard University and Massachusetts Institute of Technology, and the NCAB Chair, Tyler Jacks, Director, Koch Institute for Integrative Cancer Research, David H. Koch Professor of Biology, Massachusetts Institute of Technology, presided during the open session. Dr. Jacks presided during the closed session. BSA Members NCAB Members Dr. Todd R. Golub (Chair) Dr. Tyler E. Jacks (Chair) Dr. Francis Ali-Osman (absent) Dr. David C. Christiani (absent) Dr. Kenneth C. Anderson Dr. Marcia R. Cruz-Correa (absent) Dr. Dafna Bar-Sagi Dr. Kevin J. Cullen Dr. Ethan M.
    [Show full text]
  • Table of Contents SPR
    Table of Contents SPR ABOUT THE ANNUAL MEETING and SPR Acknowledgements ......................................................................................................... 3 Welcome from the President ............................................................................................ 7 Board of Directors .......................................................................................................... 9 Welcome from the Program Planning Committee Chair ................................................... 13 Program Committees ...................................................................................................... 14 About SPR ..................................................................................................................... 20 SPR Awards .................................................................................................................... 21 Celebrating 10 Years of Prevention Science ........................................................................ 23 MEETING PROGRAM AND ACTIVITIES Preconference Workshops ................................................................................................. 25 Diversity Network Committee and DNC Meeting Activities .............................................. 35 ECPN and ECPN Meeting Activities ................................................................................ 39 Sloboda and Bukoski SPR Cup ......................................................................................... 42 Wednesday Highlights
    [Show full text]
  • Problems of Drug Dependence 1989: Proceedings of the 51St Annual
    National Institute on Drug Abuse MONOGRAPH SERIES Problems of Drug Dependence 1989 Proceedings of the 51st Annual Scientific Meeting The Committee on Problems of Drug Dependence, Inc. U S DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Problems of Drug Dependence 1989 Proceedings of the 51st Annual Scientific Meeting The Committee on Problems of Drug Dependence, Inc. Editor: Louis S. Harris, Ph.D. NIDA Research Monograph 95 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICE Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse Off ice of Science 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National Institute on Drug Abuse and published by its Office of Science. The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. MARY L. JACOBSON Temple University School of Medicine National Federation of Parents for Philadelphia, Pennsylvania Drug-free Youth Omaha, Nebraska SYDNEY ARCHER, Ph.D. Rensselaer Polytechnic Institute Troy, New York REESE T. JONES, M.D. Langley Porter Neuropsychiatric Institute RICHARD E. BELLEVILLE, Ph.D. San Francisco, California NB Associates, Health Sciences Rockville, Maryland DENISE KANDEL, Ph.D. KARST J. BESTEMAN College of Physicians and Surgeons of Alcohol and Drug Problems Association Columbia University of North America New York, New York Washington, D.C.
    [Show full text]
  • In Search of Memory a Film by Petra Seeger
    In Search of Memory A Film by petra seeger The Neuroscientist Eric Kandel Winner of the Nobel Prize 95 minutes / color / 1.85:1 / Stereo Digital / 2008 English and German w/English Subtitles An Icarus Films Release 32 Court Street, 21st Floor, Brooklyn, NY 11201 T (718) 488 8900 / (800) 876 1710 / F (718) 488 8642 www.IcarusFilms.com / [email protected] Synopsis “Memory is everything. Without it we are nothing,” says neuroscientist Eric Kandel, winner of the Nobel Prize for his groundbreaking research on the physiology of the brain’s storage of memories. As he explains, memory is the glue that binds our mental life together and provides a sense of continuity in our lives. IN SEARCH OF MEMORY is a compelling blend of autobiography and history that recounts the life of one of the most important neuroscientists of the 20th century and illuminates scientific developments in our understanding of the brain’s role in recording and preserving memory. In addition to archival footage and dramatic re-creations of Kandel’s childhood experiences in Nazi- occupied Vienna and his formative years as an emigrant in New York, the film features discussions with Kandel, friends and family, as well as his public lectures in Vienna and New York, which explore both his professional and personal life, especially his emotional ties to Judaism. Both through its personal journey into the memory of this amazingly spry and witty 79-year old, especially his traumatic experiences during the Holocaust, and a visit to his Columbia University laboratory, where Kandel and his colleagues demonstrate their experimental research, IN SEARCH OF MEMORY examines how the brain stores memories, the difference between short-term and long-term memory, Alzheimer’s and age-related memory loss, and structural modifications to the brain that enhance memory.
    [Show full text]